Módulo 1
Conceitos gerais
Propriedades
Antimicrobianos
   ß-Lactâmicos
 Tetraciclinas
 Novos antimicrobianos
Mecanismos de ação
Bibliografia
Antimicrobianos - Base Teóricas e Uso Clínico

V. Bibliografia consultada

  1. Álvares-Lerma F, Grau S, Gracia-Arnillas MP. Gram positive cocci infections in intensive care. Drugs. 2006;66(6):751-768.
  2. Amato Neto V, Nicodemo AC, Lopes HV. Antibióticos na prática clínica. 6ª ed. São Paulo: Sarvier Editora; 2007.
  3. Anderson DL. Doripenem. Drugs of Today. 2006; 42 (6): 399-404.
  4. Appelbaum PC and Jacobs MR. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria. Curr Opin Microbiol. 2005; 5: 510-517. Acessível em:
    http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6VS2-4GV9SRG-1-1&_cdi=6250&_user=984616&_orig=browse&_coverDate=10/31/2005&_sk=999919994&view=c&wchp=dGLbVtb-zSkWA&_valck=1&md5=aa97f07e562b415ef734a70ea21da2f0&ie=/sdarticle.pdf
  5. Drusano GL. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin Infect Dis; 2007:45 (supp 1):S89-95.
  6. Falagas ME and Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrud-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:133-41. Acessível em:
    http://www.journals.uchicago.edu/CID/journal/issues/v40n9/35354/35354.web.pdf
  7. Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobiol therapy. 36th ed. Hyde Park, VT: Antimicrobial Therapy Inc.; 2006.
  8. Hsieh YC, Wang JT, Lee WS, et al. Serotype competence and penicillin resistance in Streptococcus pneumoniae. Emerg Infect Dis. 2006; 12 (11): 1709-1714. Acessível aqui.
  9. Mandell GL, Douglas RG, Bennett JE Dolin R. Principles and practice of infectious disease. 6ª ed.  Philadelphia. Churchill Livingstone Ed. 2004.
  10. Noel GJ. Clinical profile of ceftobiprole, a novel beta-lactam antibiotic. Clin Microbiol Infect. 2007;13 (Suppl 2): 25-9.  Acessível em:
    http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1469-0691.2007.01725.x
  11. Paterson DL. Clinical experience with recently approved antibiotics. Curr Opin Pharmacol. 2006;6:486-90. Acessível em:
    http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6W7F-4KKWVWB-3-1&_cdi=6625&_user=984616&_orig=browse&_coverDate=10/31/2006&_sk=999939994&view=c&wchp=dGLbVlz-zSkzk&md5=2f84f2cc2cb236d66478de983ee4c241&ie=/sdarticle.pdf
  12. Reinert RR, van der Linden M, Seegmuller I, et al. Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clin Microbiol Infect. 2007; 13 (4): 363-368. Acessível em:
    http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1469-0691.2006.01676.x
  13. Silva JG and Carvalho I. New insights into aminoglycoside antibiotics and derivates. Curr Med Chem. 2007; 14 (10): 1101-19.
  14. Veronesi R., Focaccia R. Tratado de Infectologia. 3ª ed. São Paulo: Ed Atheneu; 2005.
  15. Walter Tavares. Antibióticos e Quimioterápicos para o clínico. 1ª ed. São Paulo: Atheneu; 2006.
« voltar